A patient with idiopathic inflammation of the right orbit, established by biopsy, developed episodes of transient left sensorimotor hemiparesis. Neuroimaging showed intracranial extension of the disease with pronounced narrowing of the right internal carotid artery in its intracavernous portion. Oral cyclophosphamide induced gradual improvement. Transient ischaemic attack is rarely found in association with orbital disease and indicates possible intracranial extension. (J Neurol Neurosurg Psychiatry 1995;58:88-90) 
Idiopathic orbital inflammation, previously known as orbital inflammatory pseudotumour, is a non-specific idiopathic inflammatory process that can involve any tissue of the orbit. Painful exophthalmos is a hallmark of the disease, as is its response to corticosteroid treatment. Visual loss is the major complication and may be related to optic nerve compression, retinal detachment, intraocular inflammation, glaucoma, or retinal vascular occlusion. ' impressively, the process extended intracranially through the superior orbital fissure into the right cavernous sinus and along the right tentorial edge (fig 1) The diagnosis of idiopathic orbital inflammation was established and oral cyclophosphamide (100 mg per day) was added to the previous treatment (prednisone (40 mg) and rifampicin (600 mg) daily). Gradual and slow improvement of vision, oculomotility, exophthalmos, and pain ensued. In December 1993 prednisone and rifampicin were discontinued and the patient was given 100 mg cyclophosphamide per day only.
Evolution was favourable and in January 1994 no more abnormal tissue was found on MRI with gadolinium injection. Repeat MRA showed no improvement of flow within the right internal carotid artery. On 25 April 1994, the patient was still taking 100 mg cyclophosphamide daily. Right eye visual acuity was 20/40, colour vision was 5/17 (Ishihara), optic atrophy was present, and the Goldmann visual field was moderately concentrically narrowed. Enophthalmos of the right eye was then present (4 mm). Oculomotility had partially recovered (abduction 80%, adduction 80%, supraduction 60%, infraduction 0%) with a positive forced duction test. The left eye was normal. Transient ischaemic attacks had not recurred.
Discussion
Eight months after the onset of the disease, intracranial extension of idiopathic orbital inflammation was heralded by transient left hemiparesis and hemiparaesthesia. MRI revealed extension of idiopathic orbital inflammation in the orbit with, firstly, myositis and posterior scleritis and, secondly, spreading through the superior orbital fissure and optic canal. Furthermore, left cavernous sinus invasion, extension along the cerebellar tentorial edge towards the posterior fossa, and severe internal carotid artery stenosis were found on MRI and MRA (figs 1 and 2) .
Intracranial extension of an orbital process thought to be idiopathic orbital inflammation should raise suspicion and the diagnosis should be reconsidered unless proved by extensive biopsy.2 We obtained two extensive biopsies from our patient, the first before neuroradiological evidence of intracranial extension and the second when intracranial extension was present, each consistent with idiopathic orbital inflammation. Orbital exploration or biopsy of such cases are well known to exacerbate the inflammatory process and such manoeuvres should be performed only when the diagnosis is questioned by the unusual course of the disease. Indeed in our case intracranial extension could have been promoted by both biopsy and optic canal unroofing, leaving an opening to the endocranium. Such an intracranial extension, however, has been described without previous biopsy or decompressive procedure.3479 10 Eighteen cases of extraorbital extension of idiopathic orbital inflammation have been reported to date, proved by biopsy in 10 of them.3-10 Erosion of bone was present in eight cases; extension through the superior orbital fissure in 11, through an inferior orbital fissure in two, and through the optic canal in one. The cavernous sinus was invaded in nine patients and thick enhancing meninges were detected in four patients. Middle cranial fossa was invaded in 10 cases; posterior, infratemporal, and pterygopalatine fossa in one case each. A large intracranial mass was found in one case. Despite extensive disease, neurological signs of intracranial extension were scarce: one case of seizure,3 one case of hydrocephalus-dementia-ataxia,5 and one case of transient hemiparesis.7 Mechanisms for the last complication were not specified. In our patient, MRI and MRA showed tight narrowing of the right intracavernous internal carotid artery due to extension of disease, which is consistent with a history of repeated transient ischaemic attacks in the territory of the middle cerebral artery.
High dose oral corticosteroids are usually the treatment of choice in idiopathic orbital inflammation. Before the era of modern neuroimaging techniques, it was even considered as a therapeutic test. Our patient failed to respond to therapeutic doses of steroids and only partial improvement was achieved with doses of up to 1-5 mg/kg daily. Radiotherapy was considered, but results from biopsy showed a preponderance of fibrotic tissue and this treatment was discarded. As inflammatory cells were mostly T cell lymphocytes, oral cyclophosphamide was started in July 1993. With a 100 mg daily dose of cyclophosphamide, gradual improvement ensued over the next seven months. Neurological symptoms never recurred. Pain and exophthalmos completely disappeared and oculomotility and visual acuity partially recovered.
This case emphasises the variety of symptoms and the aggressive behaviour that can be encountered with idiopathic orbital inflammation. To our knowledge, transient ischaemic attacks with hemiparesis have been reported only once apart from the present case.
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